ABVAX
Price
$21.62
Change
-$0.00 (-0.00%)
Updated
Jul 13 closing price
Net Assets
531.76M
RMEBX
Price
$64.23
Change
-$0.20 (-0.31%)
Updated
Jul 13 closing price
Net Assets
118.05B
Interact to see
Advertisement

ABVAX vs RMEBX

ABVAX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
ABVAX vs. RMEBX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVAX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. ABVAX (532M). RMEBX pays higher dividends than ABVAX: RMEBX (1.00) vs ABVAX (0.89). ABVAX was incepted earlier than RMEBX: ABVAX (25 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than ABVAX (0.89). ABVAX is a more actively managed with annual turnover of: 48.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than ABVAX: RMEBX (250) vs ABVAX (2500). ABVAX annual gain was more profitable for investors over the last year : 22.66 vs. RMEBX (8.73). RMEBX return over 5 years is better than : 36.28 vs. ABVAX (23.25).
ABVAXRMEBXABVAX / RMEBX
Total Expense Ratio0.891.0783%
Annual Report Gross Expense Ratio0.891.0783%
Fund Existence25 years12 years-
Gain YTD19.7789.059218%
Front Load4%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets532M118B0%
Annual Yield % from dividends0.891.0089%
Returns for 1 year22.668.73260%
Returns for 3 years36.4234.30106%
Returns for 5 years23.2536.2864%
Returns for 10 years74.7989.3684%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JSPR0.610.03
+4.90%
Jasper Therapeutics
FINV4.570.03
+0.66%
FinVolution Group
UNF272.931.15
+0.42%
Unifirst Corp
AIFU35.00-1.56
-4.27%
AIFU Inc
COHR307.39-17.11
-5.27%
Coherent Corp